Hormone Replacement Therapy (HRT) – (pending) $772 million set aside so far - Consumer Justice Foundation

Hormone Replacement Therapy (HRT) – (pending) $772 million set aside so far

Written by Andrew Sarski on June 8, 2012
Consumer Justice Foundation Seal

Wyeth Pharmaceuticals, a subsidiary of Pfizer, is facing a class action lawsuit filed on behalf of women who used the company’s hormone replacement therapy (HRT) and subsequently developed breast cancer. According to the suit, Wyeth allegedly failed to warn patients using the firm’s Premplus and Premarin therapies about studies that showed a connection between HRT and breast cancer. Wyeth has reportedly set aside $772 million to resolve HRT personal injury claims.

Posted Under: Verdicts & Settlements
Start Claim Now
Do you deserve compensation?

An attorney will review your situation for FREE and help you found out what really went wrong.

How Can We Reach You?

Please Explain Your Situation

By clicking the "Submit" button below, you agree that law firms you are matched with may contact you by telephone even if you are on a federal or state Do Not Call registry. Up to 10 law firms may respond to your request within approximately 2 weeks. In some cases 3 or more firms may respond to your request after 30 days. Use of this site is subject to our Terms of Use.
×